Skip to main content

Launching the First Non-Invasive Point of Care Diagnostic Test for Traumatic Brain Injury

Project description

A biochemical test for traumatic brain injury diagnosis

Doctors in an emergency room reach diagnosis of a suspected traumatic brain injury (TBI) using a combination of CT and MRI scans as well as a neurological evaluation. The EU-funded Medicortex project has developed an alternative TBI diagnostic method which is fast and easy to use and can be performed at the point of care, offering immediate results. The test is based on TBI-specific biomarkers that can be detected in saliva and urine samples, and it has great potential to improve the clinical outcome of millions of people with TBI worldwide.

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-1

Coordinator

MEDICORTEX FINLAND OY
Net EU contribution
€ 50 000,00
Address
Itainen Pitkakatu 4b 4
20520 Turku
Finland

See on map

Region
Manner-Suomi Etelä-Suomi Varsinais-Suomi
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 50 000,00